相关实验视频

Updated: Jun 23, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

针对癌症免疫疗法免疫抑制性瘤微环境中的多态核核髓衍生抑制细胞

Shiqi Li¹, Xinghua Long¹

¹Department of Laboratory Medicine Zhongnan Hospital of Wuhan University Wuhan China.

|June 24, 2024

概括

研究人员确定了CD300ld在多态核核髓衍生抑制细胞 (PMN-MDSCs) 上作为癌症免疫治疗的关键标. 阻断CD300ld可以通过调节PMN-MDSCs来增强抗瘤免疫力,提供了一个有前途的新疗法策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

瘤诱导的免疫抑制会阻碍宿主免疫系统,促进癌症的生长和转移.
免疫抑制髓质细胞,特别是多态核核髓质衍生抑制细胞 (PMN-MDSCs),在瘤发育和免疫疗法耐药性方面至关重要.
识别调节PMN-MDSCs的分子标对于有效的癌症免疫疗法至关重要.

研究的目的:

调查表达在PMN-MDSCs上的CD300ld在瘤驱动免疫抑制中的作用.
确定CD300ld作为重塑瘤免疫微环境的新型治疗标.
评估针对CD300ld具有广泛的抗瘤作用的潜力.

主要方法:

该研究确定CD300ld是一种新型,高度保守的瘤免疫抑制受体.
具体分析了PMN-MDSCs上的CD300ld表达.
研究了CD300ld在调节PMN-MDSC招募和免疫抑制活性方面的功能.

主要成果:

CD300ld在PMN-MDSCs上高度表达,并在瘤驱动的免疫抑制中发挥关键作用.
向CD300ld被证明可以抑制PMN-MDSC的招募和功能.
这种抑制有效地重塑了瘤免疫微环境,导致了广泛的抗瘤效应.

结论:

CD300ld是PMN-MDSCs的新和保存目标,对于瘤免疫逃避至关重要.
向CD300ld为癌症免疫治疗提供了一个有前途的策略,具有广泛应用的潜力.
CD300ld证明了安全性,保存性,抗瘤功效以及与PD-1抑制剂等现有疗法的协同作用潜力.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...